Researchers have identified several factors that may contribute to variability in drug efficacy observed during clinical evaluation. Preliminary findings suggest that biological, demographic, and treatment-related variables can influence individual response outcomes.

Understanding these factors is expected to enhance trial design and inform more precise patient stratification strategies. Ongoing analyses aim to further clarify these relationships and support the development of more targeted and effective therapeutic approaches.